Connor, Clark & Lunn Investment Management (CC&L)’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $291K | Hold |
|
|||||
|
2023
Q4 | $252K | Sell |
|
|||||
|
2023
Q3 | $310K | Buy |
|
|||||
|
2023
Q2 | $362K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $112K | Buy |
|
|||||
|
2021
Q3 | $120K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $56K | Sell |
|
|||||
|
2020
Q2 | $162K | Sell |
|
|||||
|
2020
Q1 | $126K | Buy |
|
|||||
|
2019
Q4 | $90K | Buy |
|